Home › Funds › Royce & Associates › ASTH
Royce & Associates position in ASTH
ASTRANA HEALTH INC · Consumer Discretionary
Latest position (Q2 2026)472.48K sh
Reported value held$21.93M
Portfolio Weight0.18%
First reportedQ1 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 14.97K | $628.51K | New |
| Q2 2024 | 14.97K | $607.10K | Hold |
| Q3 2024 | 114.97K | $6.66M | Add |
| Q4 2024 | 255.55K | $8.06M | Add |
| Q1 2025 | 290.71K | $9.01M | Add |
| Q2 2025 | 307.49K | $7.65M | Add |
| Q3 2025 | 259.35K | $7.35M | Reduce |
| Q4 2025 | 348.33K | $8.64M | Add |
| Q1 2026 | 396.96K | $9.73M | Add |
| Q2 2026 | 472.48K | $21.93M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ASTH
- BlackRock Inc 6.90M sh · $320.23M · Q2 2026
- Vanguard Group 4.24M sh · $105.15M · Q4 2025
- Wellington Management Group 1.29M sh · $59.99M · Q2 2026
- Geode Capital Management 1.17M sh · $54.22M · Q2 2026
- Bank of America Corp 852.14K sh · $39.55M · Q2 2026
- Fidelity Management & Research (FMR) 685.92K sh · $31.83M · Q2 2026
- Wells Fargo & Co 664.94K sh · $30.86M · Q2 2026
- Charles Schwab Investment Management 652.67K sh · $30.29M · Q2 2026
- Northern Trust Corp 505.04K sh · $23.44M · Q2 2026
- Morgan Stanley 433.51K sh · $20.12M · Q2 2026
- Invesco Ltd 381.83K sh · $17.72M · Q2 2026